Sequenom falls on test delay

Sequenom Inc. (NASDAQ:SQNM) fell $11.29 (76%) to $3.62 on Thursday after reporting late Wednesday that it delayed the expected June launch date for its SEQureDx Down syndrome test due to "employee mis...